Last week, interim results from Pfizer suggested its vaccine reduces cases of COVID-19 with 90% efficacy.
- Simon Kolstoe
- The Conversation
Now Moderna has gone one better, with interim results showing nearly 95% efficacy for its vaccine – with hints that it may protect against severe disease.
Neither have reported any serious safety concerns and have tested their vaccines in tens of thousands of participants.
With so many COVID-19 vaccines in development, more…